Exclusive: Cellens raises $6.5M to ad-vance physics-based test for bladder cancer
Boston-based company Cellens secured $6.5 million to develop its platform that detects bladder cancer through an approach that combines physics and AI, End-points News learned exclusively. Its technology is a departure from the norm in cancer diagnostics, in which scientists largely rely on molecular markers inside the cell. Cellens uses atomic force microscopy, which “feels” […]
